Diateca

Bookmark and Share

Progetto vincitore della Borsa di Studio "Andrea Mezzetti" 2016

 

 

Effect of apolipoprotein A-I on microbiota: a new mechanism of HDL-mediated atheroprotection?

Marco Busnelli

 


Abstract:


Background. The small intestine, together with the liver, is responsible for the synthesis of apoA-I, the most abundant protein of HDL. Moreover, the intestine harbors trillions of microbes, the so-called gut microbiota, that play a crucial role in host metabolic processes and, in particular, can influence cholesterol and bile acids metabolism. Interestingly, inflammatory conditions of the small intestine are associated with a downregulation of the APOA1 gene and lead to an altered microbiota composition.

Objectives
. The proposed project is aimed at demonstrating, for the first time, that apoA-I can modulate intestinal homeostasis and microbiota composition and notably, that an apoA-I deficiency-driven dysbiosis can predispose to atherosclerosis development. This hypothesis is supported by two independent observations that have never been merged so far: i) apoA-I deficient mice have an altered microbiota composition, enriched in choline-degrading bacteria; ii) the gut microbiota can influence atherosclerosis development by processing dietary choline to trimethylamine, further metabolized to trimethylamine N-oxide (TMAO) by hepatic flavin mono-oxygenase.

Methods
. The research strategy will be based on the use of both conventional and germ-free, atherosclerosis prone mice. In conventional genetically modified mice, lacking or overexpressing apoA-I, the effects of apoA-I and dietary choline on: i) atherosclerosis development; ii) TMAO production; iii) gut/liver homeostasis; iv) microbiota composition, will be evaluated. In addition, microbiota transfer from those mice to atherosclerosis-prone germ-free animals will be used to assess to what extent a deficit of apoA-I makes the gut microbiota harmful for atherosclerosis development.

Expected results.
i) To demonstrate whether apoA-I deficiency promotes the presence of TMAO-producing bacteria in the gut that worsen atherosclerosis development; ii) to clarify how apoA-I modulates gut microbiota composition.


 

 

 

Presentazione del progetto vincitore della Borsa di Studio “Andrea Mezzetti” - 2016

 

 

 


Area Soci

Eventi

33° Congresso Nazionale


33° Congresso Nazionale

Roma, 24-26 novembre 2019
Save the date

[continua a leggere]

Congresso congiunto SIIA umbro-marchigiana SISA Umbria 2019

Narni (TR), 2 Marzo 2019

[continua a leggere]

Spring Meeting Gruppi Giovani SIIA, SIMI, SISA 2019

Rimini,
28 febbraio - 2 marzo 2019

[continua a leggere]

EAS Advanced Course in Rare Lipid Disease

Cinisello B.mo (Mi), 19 Ottobre 2018

[continua a leggere]

Giornale Italiano Arteriosclerosi

Rivista in lingua italiana
riservata ai Soci S.I.S.A.
Ultimo numero:
Anno 9 • N.4/2018

[continua a leggere]

Rivista NMCD

Nutrition, Metabolism and Cardiovascular Diseases

Istruzioni per l'accesso online

IF 2017: 3.318


Newsletter

Per essere informati sulle novità di S.I.S.A. iscrivetevi alla nostra newsletter inserendo
il vostro indirizzo di posta elettronica

Progetto LIPIGEN

LIPIGEN
Nuovo sito dedicato al Progetto LIPIGEN

 

Progetto LIPIGEN - Vecchio portale
E' necessario essere loggati come utente
Lipigen per poter accedere alla pagina

PROject Statin Intolerance SISA

 

PROSISA – PROject Statin Intolerance SISA
E' necessario essere loggati come utente
PROSISA per poter accedere alla pagina

GILA - Lipoprotein Aferesi

 

Gruppo Interdisciplinare Lipoprotein Aferesi
(Accesso Gruppo GILA-Lipoprotein Aferesi)

E' necessario essere loggati come utente del Gruppo GILA per poter accedere

 

Gruppo Interdisciplinare Lipoprotein Aferesi
(Documentazione ad accesso libero)

Pagina informativa per medici e pazienti